NCT03092531Completed
Positive Steps to Enhance Problem Solving Skills
Adaptive Intervention Strategies Trial for Strengthening Adherence to Antiretroviral HIV Treatment Among Youth
Source: ClinicalTrials.gov · Last updated 25 Jul 2024
Brief summary (registry, in English)
This randomized control trial is to test the efficacy of a stepped-care "adaptive" Antiretroviral Therapy (ART) adherence intervention ("Positive STEPS") for HIV infected adolescents and young adults, ages 16 to 29. Stepped care is a healthcare delivery model in which the least resource intensive part of an intervention is delivered first, and only those who do not improve then receive the high intensity, more resource intensive part of an intervention.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 123 (actual)
- First submitted
- 10 Mar 2017
- Start date
- 1 Feb 2018
- Primary completion date
- 30 Jun 2024
- Lead sponsor
- University of California, Los Angeles
- Diseases
- HIV
- NCT number
- NCT03092531
What you commit to
- Study type: Interventional
- Participants enrolled: 123
- From 1 Feb 2018 to the primary completion date, 30 Jun 2024
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Not currently on antiretroviral therapy
- Self-reports \> 90% ART medication adherence in the past month AND has been taking ART for more than 3 months
Other illness
- Unable to give informed consent due to severe mental or physical illness, cognitive limitation, or substance intoxication at baseline visit
- HIV-uninfected
Other
- Does not own a cell phone
- Has lived in the greater Providence, Boston, or Chicago area for less than three months or is planning to move outside the area within the next year
- Unable to speak and understand English
- Currently enrolled in another ART-adherence intervention study
- Not willing to and able to complete all study visits in person or remotely via video conferencing platform
Who the study is looking for
- Between 16 and 29 years of age
- HIV-infected (perinatally, transfusion, or behaviorally-acquired)
- Currently taking or prescribed antiretroviral therapy and: 1) Began taking ART \< 3 months ago, OR 2) Has been taking ART for \>3 AND has missed one or more doses in the past week or more than 3 doses in the past month.
- Daily access to a cell phone
- Has lived in the greater Providence, Boston, or Chicago area greater than three months
- Self-reports \< 90% ART medication adherence in the past month (i.e., missed one or more doses in the past week or more than 3 doses in the past month) at screening
- Able to speak and understand English
- Not currently enrolled in another ART-adherence intervention study
- Willing and able to complete all study visits in person or remotely via video conferencing platform
Age in the registry: 16 years to 29 years · Sex: All · Accepts healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fenway Health Institute Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
| Lurie Childrens Hospital Coordinator of this site? Confirm its status | Chicago | United States | Unknown status |
| UCLA Center for LGBTQ+ Advocacy, Research & Health Coordinator of this site? Confirm its status | Los Angeles | United States | Unknown status |
| Brown University School of Public Health Coordinator of this site? Confirm its status | Providence | United States | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.